북미 및 유럽의 반려조류용 의료 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 유통 채널별, 지역별, 부문별 예측(2024-2030년)

North America And Europe Pet Birds Health Market Growth & Trends:

The North America and Europe pet birds health market size is anticipated to reach USD 849.8 million by 2030 and is projected to grow at a CAGR of 7.80% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of bacterial infections in pet birds, rising adoption of pet insurance, and increasing birds ownership are key factors driving the market growth. Moreover, the increasing availability and development of specialized pharmaceuticals and supplements for pet birds are vital. These products address common health issues, such as nutritional deficiencies, respiratory conditions, and organ function, contributing to market growth.

The increasing adoption of pet bird health insurance is contributing significantly to the market growth. As bird ownership rises, more pet owners seek to provide comprehensive care for their birds, driving demand for specialized health insurance plans. With insurance covering a range of veterinary services, owners are more inclined to seek timely and proper medical care for their birds, boosting demand for veterinary services, pharmaceuticals, and diagnostic tools. This, in turn, stimulates growth in the broader pet bird health market as more advanced and specialized care becomes accessible through insurance coverage. For instance, Nationwide offers pet insurance plans for birds. The insurance plans cover conditions that specifically affect birds, from internal parasites to liver disease. Moreover, according to Nationwide, a bird insurance plan's monthly premium typically starts at less than USD 21 per month and varies depending on the type of coverage chosen.

The rising prevalence of diseases in birds significantly drives the market by increasing the demand for specialized healthcare services and products. According to an article published by the World Organization for Animal Health, avian influenza is a highly contagious viral disease that affects both domestic and wild birds. Common avian diseases like psittacosis, avian influenza, and various parasitic and bacterial infections create a growing need for advanced diagnostic tools, vaccines, and treatments. Bird owners are becoming more aware of the importance of preventive healthcare, leading to increased veterinary visits, the adoption of health supplements, and demand for pharmaceuticals designed specifically for birds. Technological advancements in diagnostics, along with the development of more effective vaccines and treatments, are further accelerating this market. In addition, the growing focus on avian wellness by breeders and pet owners, in response to disease risks, boosts sales in both diagnostic and pharmaceutical segments. E-commerce platforms also make it easier to access a wider range of bird-specific health products, increasing their availability and driving market growth.

North America And Europe Pet Birds Health Market Report Highlights:

• The pharmaceuticals segment led the market with the largest revenue share of 58.33% in 2023. Bacterial and fungal infections are common among pet birds, necessitating the use of targeted pharmaceuticals. The availability of advanced antibiotics and antifungals tailored for birds has supported market growth
• Based on application, the bacterial infections segment led the market with the largest revenue share of 48.57% in 2023
• Based on distribution channel, the veterinary hospitals/clinics segment led the market with the largest revenue share of 49.48% in 2023
• Europe dominated the market with the largest revenue share of 54% in 2023 and is anticipated to grow at the fastest CAGR of 7% during the forecast period

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. North America Pet Birds Health Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing birds ownership
    • 3.2.1.2. Rising prevalence of bacterial and fungal infection
    • 3.2.1.3. Rising adoption of pet birds insurance
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of specialized veterinary expertise
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
  • 3.2.5. Industry Analysis - Porter's
    • 3.2.5.1. Bargaining power of the suppliers
    • 3.2.5.2. Bargaining power of the buyers
    • 3.2.5.3. Threats of substitution
    • 3.2.5.4. Threats from new entrants
    • 3.2.5.5. Competitive rivalry
  • 3.2.6. PESTEL Analysis
    • 3.2.6.1. Political landscape
    • 3.2.6.2. Economic and Social landscape
    • 3.2.6.3. Technological landscape
• 3.3. Pricing Analysis
• 3.4. Regulatory framework
• 3.5. Estimated Birds Population By key countries, 2023
• 3.6. COVID-19 Impact Analysis

Chapter 4. North America Pet Birds Health Market: By Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. North America Pet Birds Health Market: By Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.2.1. Pharmaceuticals
    • 4.2.1.1. Pharmaceuticals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.1.2. Anti Parasitic
      • 4.2.1.2.1. Anti Parasitic Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.1.3. Antibiotics
      • 4.2.1.3.1. Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.1.4. Antifungal
      • 4.2.1.4.1. Antifungal Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.1.5. Nutritional Supplements
      • 4.2.1.5.1. Nutritional Supplements Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.2.2. Diagnostics
    • 4.2.2.1. Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2.2. Consumables, reagents and kits
      • 4.2.2.2.1. Consumables, reagents, and kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2.3. Instruments and devices
      • 4.2.2.3.1. Instruments and devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.2.3. Others
    • 4.2.3.1. Other Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America Pet Birds Health Market: By Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. North America Pet Birds Health Market: By Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.2.1. Bacterial Infection
    • 5.2.1.1. Bacterial Infection Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.2.2. Parasitic Infestations
    • 5.2.2.1. Parasitic Infestations Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.2.3. Others
    • 5.2.3.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America Pet Birds Health Market: By Distribution Channel Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. North America Pet Birds Health Market: By Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
  • 6.2.1. Veterinary Hospitals/ Clinics
    • 6.2.1.1. Veterinary Hospital/ Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. Retail
    • 6.2.2.1. Retail Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. E-commerce
    • 6.2.3.1. E-commerce Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. North America Pet Birds Health Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Denmark market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Participant Categorization
• 8.2. Company Market Position Analysis/ Heap Map Analysis
• 8.3. Company Profile
  • 8.3.1. AdvaCare Pharma
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Thermo Fisher Scientific Inc.
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. INDICAL BIOSCIENCE GmbH
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Vetafarm
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. VioVet Ltd (Pethealth)
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Zoetis
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. HomeoPet LLC.
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Vetnil
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Merck & Co., Inc
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Johnsons
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
• 8.4. Strategy Mapping
  • 8.4.1. Mergers & Acquisitions
  • 8.4.2. Partnerships & Collaborations
  • 8.4.3. Expansion
  • 8.4.4. Product launch
  • 8.4.5. Others
• 8.5. List of other Key players